ThromboGenics Struggles to Find Patients for Phase II Eye Disease Trial Post author:Sam Post published:December 7, 2017 Post category:BioPharma Resources redirected to progress new drug candidates to clinic in H1 2018. Source: BioSpace You Might Also Like DaVita Clinical Research Launches Alliance Site Network For Early Stage CKD Trials June 14, 2017 Sanofi: Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function i… October 30, 2017 Bay Area's Kindred Bio Scoops Up Boehringer Ingelheim's Former Space in Kansas June 25, 2017
Sanofi: Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function i… October 30, 2017
